About: Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2
Creator	Allegorico, E Altruda, C Arbo, P Bosso, G Dello Vicario, F Minerva, V Numis, F Pagano, A Pagano, Antonio Porta, G Russo, T Serra, C T°, Russo Vicario, Dello
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: During the COVID-19 outbreak, a very high number of infected patients developed pneumonia and many of them complicated with acute respiratory distress syndrome. The optimal management of respiratory failure and the role of lung ultrasound imaging in the evaluation of efficacy of treatment are unknown. METHODS: In March 2020 we treated 18 patients with mild and moderate ARDS secondary to SARS-CoV-2 with non-invasive continuous positive airway pressure therapy (NI-CPAP). All patients underwent lung ultrasound imaging to verify the entity of lung recruitment after NI-CPAP initiation. RESULTS: After one hour of treatment we observed a significant improvement in PaO2/FiO2 ratio in 10 patients. Notably, only 50% of them reached an effective improvement in lung aeration detectable with lung ultrasound. In the other 50% or patients the improvement in PaO2/FiO2 might be related to blood redistribution and reverse of hypoxic vasoconstriction. CONCLUSION: NI- CPAP is a valid therapeutic option in mild and moderate ARDS secondary SARS-CoV-2. Lung recruitment detected by means of lung ultrasound is a relevant but not the exclusive mechanism that underlies the therapeutic efficacy of NI-CPAP in this clinical setting.
has issue date	2020-07-03(xsd:dateTime)
bibo:doi	10.1016/j.resp.2020.103489
bibo:pmid	32629100
has license	no-cc
sha1sum (hex)	84347d16f283c16a82903210c8b63239c05d59b2
schema:url	https://doi.org/10.1016/j.resp.2020.103489
resource representing a document's title	Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2
has PubMed Central identifier	PMC7332943
has PubMed identifier	32629100
schema:publication	Respir Physiol Neurobiol
resource representing a document's body	covid:84347d16f283c16a82903210c8b63239c05d59b2#body_text
is schema:about of	covid:arg/84347d16f283c16a82903210c8b63239c05d59b2 named entity 'CPAP' named entity 'SARS-CoV-2' named entity 'continuous positive airway pressure' named entity 'lung' named entity 'lung' named entity 'Lung' named entity 'ultrasound' named entity 'non-invasive' named entity 'SARS-CoV-2' named entity 'clinical setting' named entity 'PaO2/FiO2 ratio' named entity 'Respiratory Physiology' named entity 'chest wall' named entity 'hypoxemia' named entity 'COVID-19' named entity 'ARDS' named entity 'tomography' named entity 'D-Dimer' named entity 'FiO2' named entity 'CPAP' named entity 'infectious disease' named entity 'partial pressure' named entity 'ARDS' named entity 'NIV' named entity 'Thorax' named entity 'ARDS' named entity 'Coronavirus' named entity 'ultrasound' named entity 'lung tissue' named entity 'invasive mechanical ventilation' named entity 'two-tailed test' named entity 'ARDS' named entity 'CPAP' named entity 'PaO2/FiO2' named entity 'nursing staff' named entity 'ventilation/perfusion ratio' named entity 'acute respiratory failure' named entity 'ARDS' named entity 'lung' named entity 'PaO2/FiO2' named entity 'CPAP' named entity 'NIV' named entity 'Venturi mask' named entity 'PaO2/FiO2 ratio' named entity 'CPAP' named entity 'COVID-19' named entity 'PaO2/FiO2' named entity 'Samsung' named entity 'invasive ventilation' named entity 'mortality rate' named entity 'hypoxic vasoconstriction' named entity 'lung' named entity 'PaO2/FiO2 ratio' named entity 'lateral' named entity 'PEEP' named entity 'ANOVA' named entity 'pulmonary complications' named entity 'COVID-19 infection' named entity 'FiO2' named entity 'alveoli' named entity 'multiorgan failure' named entity 'PEEP' named entity 'non-rebreather mask' named entity 'prognosis' named entity 'FiO2' named entity 'chest imaging' named entity 'lymphocytes'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software